Health Today: Non Hodgkin Lymphoma Survival Rate.

Non Hodgkin Lymphoma survival rate are broadly different. It differs because of different factors like the type of lymphoma, its stage, the age of the person, and others. As said by the American Cancer Society, the general 5-year survival rate of people suffering from Non-Hodgkin Lymphoma is 63% while the survival rate is only at 51% in terms of the 10-year span. The relative survival rate estimates the likelihood that a patient will survive a certain period of time after diagnosis. It is calculated not including other incurable diseases other than cancer.

It is impossible to get the exact projection for Non Hodgkin Lymphoma survival rate because the position has too many variables. Patients with indolent or slow growing lymphomas can survive for many years but those who were diagnosed during the late stages have lower chances of staying too long because the cancer has already spread. Aggressive lymphomas can devastate the body faster causing hasty death however there is still hope because this illness is curable.

Progress in medical technology and important discoveries in research has increased Non Hodgkin Lymphoma survival rate. The developments in treatments grew in the past 20 years, particularly to those who are under the age of 45.

Follicular lymphoma is the most common indolent Non Hodgkin Lymphoma. They are can possibly be cured at stages 1 and 2 however it is very difficult to detect and by the time it is normally diagnosed, it is already in critical stages. In general, this type of Non Hodgkin Lymphoma survival rate is 7- 10 years, depending on other risk factors. Also, recent drug treatments have significantly developed the survival rates.

High grade aggressive lymphomas may be diagnosed at once because it is symptomatic even if it is still in the early stages. They are possible to be cured by belligerent treatments. Diffuse b-cell lymphoma on the other hand is the most common aggressive Non Hodgkin Lymphoma, it can be cured with combinations of exhaustive chemotherapy but fatal if dealt with nonchalance and not treated. This type of Non Hodgkin Lymphoma survival rate depends on five risk factors. The five factors are the following: a) being older than 60, b) patient’s functional ability, c), disease that spread more than one site beyond the lymph nodes, d) having elevated levels of the lactate dehydrogenase (LDH) protein, and lastly e) having a disseminated tumor (stage 3 and 4). If the patient has none of the risk factors, then outlook is positive and good, while having two factors indicate a low-to intermediate poor outlook, three factors predict an intermediate to high likelihood of poor outlook while if one has all the risk factors, the Non Hodgkin Lymphoma survival rate is very poor.

With enough optimism and vigilance, there are many advances in technology that helps improve Non Hodgkin Lymphoma survival rate.